Links

Tools

Export citation

Search in Google Scholar

Validation of GATE 6.1 for targeted radiotherapy of metastic melanoma using 131I-labeled benzamide

Journal article published in 2012 by Y. Perrot ORCID, L. Maigne, Vincent Breton ORCID, D. Donnarieix
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown

Abstract

The GATE 6.1 Monte Carlo simulation platform based on the GEANT4 toolkit is in constant improvement for dosimetric calculations. Here, we explore its use for calculating internal absorbed dose distribution in mice for the treatment of malignant melanoma after injection of a new specific radiopharmaceutical labeled with iodine 131. We estimate the dosimetric accuracy of GATE 6.1, by calculating first S values and by comparing them and absorbed doses to organswith EGSnrc for a digital mouse phantom and a CT scan based mouse phantom.